The FDA granted fast track status to ADCE-D01, a targeted drug in early trials for soft tissue sarcoma, to speed development ...
Inhibrx Biosciences said on Thursday its experimental drug helped slow the progression of a rare and aggressive bone cancer ...
Immutep Ltd ( ($AU:IMM) ) has issued an announcement. Immutep Limited announced positive results from its EFTISARC-NEO Phase II trial, which ...
In a personal essay for PEOPLE, TikTok star Eldiara Doucette opens up about losing her dominant arm to sarcoma and coping with the uncertainty of recurrence Eldiara Doucette At just 19 years old, ...
At 16, Eldiara Doucette felt pain in her right arm that she struggled to describe. “It could have easily been classified with a standard teenage ‘growing pains,’ which is, unfortunately, how a lot of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback